Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease

The efficacy of intravenous magnesium in terminating sustained monomorphic ventricular tachycardia was examined in this study. This therapy was found to be ineffective in aborting monomorphic ventricular tachycardia induced in the electrophysiology laboratory.

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 86; no. 11; pp. 1270 - 1272
Main Authors Farouque, H.M.Omar, Sanders, Prashanthan, Young, Glenn D
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.12.2000
Elsevier
Elsevier Limited
Subjects
Anti-Arrhythmia Agents - administration & dosage
Antiarythmic agents
Biological and medical sciences
Cardiac arrhythmia
Cardiology
Cardiovascular disease
Cardiovascular system
Coronary Disease - complications
Coronary Disease - physiopathology
Drug therapy
Electrocardiography
Female
Heart Rate - drug effects
Humans
Infusions, Intravenous
Magnesium Sulfate - administration & dosage
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Tachycardia, Ventricular - drug therapy
Tachycardia, Ventricular - etiology
Tachycardia, Ventricular - physiopathology
Treatment Outcome
Human
Magnesium sulfate
Intravenous administration
Arrhythmia
Treatment efficiency
Cardiovascular disease
Antiarrhythmic agent
Coronary heart disease
Excitability disorder
Chemotherapy
Treatment
Heart disease
Paroxysmal ventricular tachycardia
Online AccessGet full text

Cover

More Information
Summary:The efficacy of intravenous magnesium in terminating sustained monomorphic ventricular tachycardia was examined in this study. This therapy was found to be ineffective in aborting monomorphic ventricular tachycardia induced in the electrophysiology laboratory.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(00)01219-4